CA2224256C - Methode de traitement de maladies autoimmunes spontanees et etablies chez les mammiferes - Google Patents
Methode de traitement de maladies autoimmunes spontanees et etablies chez les mammiferes Download PDFInfo
- Publication number
- CA2224256C CA2224256C CA 2224256 CA2224256A CA2224256C CA 2224256 C CA2224256 C CA 2224256C CA 2224256 CA2224256 CA 2224256 CA 2224256 A CA2224256 A CA 2224256A CA 2224256 C CA2224256 C CA 2224256C
- Authority
- CA
- Canada
- Prior art keywords
- compound
- mitogenic
- antibody
- group
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2224256 CA2224256C (fr) | 1997-12-09 | 1997-12-09 | Methode de traitement de maladies autoimmunes spontanees et etablies chez les mammiferes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2224256 CA2224256C (fr) | 1997-12-09 | 1997-12-09 | Methode de traitement de maladies autoimmunes spontanees et etablies chez les mammiferes |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2224256A1 CA2224256A1 (fr) | 1999-06-09 |
CA2224256C true CA2224256C (fr) | 2013-04-30 |
Family
ID=29275368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2224256 Expired - Fee Related CA2224256C (fr) | 1997-12-09 | 1997-12-09 | Methode de traitement de maladies autoimmunes spontanees et etablies chez les mammiferes |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2224256C (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410824B1 (en) | 1998-12-09 | 2002-06-25 | Protein Design Labs, Inc. | Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
GB2380127A (en) * | 2001-09-26 | 2003-04-02 | Isis Innovation | Treatment of chronic joint inflammation |
CA2653387A1 (fr) | 2006-06-06 | 2007-12-21 | Tolerrx, Inc. | Administration d'anticorps anti-cd3 dans le traitement de maladies auto-immunes |
EP3019193B1 (fr) | 2013-07-10 | 2019-09-25 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Induction de lymphocytes t régulateurs spécifiques d'antigènes, médiée par des cellules apoptotiques, pour le traitement de maladies auto-immunes chez l'homme et les animaux |
-
1997
- 1997-12-09 CA CA 2224256 patent/CA2224256C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2224256A1 (fr) | 1999-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7041289B1 (en) | Method for treating established spontaneous auto-immune diseases in mammals | |
Chatenoud et al. | CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. | |
Chatenoud et al. | CD3-specific antibodies: a portal to the treatment of autoimmunity | |
JP2638652B2 (ja) | カケクチンと反応するモノクロナール抗体 | |
EP0663836B1 (fr) | Traitement d'affections auto-immunes et inflammatoires | |
TWI755763B (zh) | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 | |
DE69534528T2 (de) | Mehrstufiger kaskade-erhöhungs-impfstoff | |
WO1992007574A1 (fr) | Glycoproteines associees a des immunoglobulines a liaison membranaire et utilisees comme cibles anticorpales sur des cellules b | |
DE69133484T2 (de) | Verwendung von Staphylococcus-Enterotoxinen oder verwandte Verbindungen für Krebs-Therapie | |
US20130078238A1 (en) | Methods and Compositions for Treating Hepatitis with Anti-CD3 Immune Molecule Therapy | |
JP2002540771A (ja) | 抗体構築物およびケモカイン構築物ならびに自己免疫疾患の治療におけるそれらの使用 | |
EP0493446B1 (fr) | Traitement de maladies auto-immunitaires | |
CA2224256C (fr) | Methode de traitement de maladies autoimmunes spontanees et etablies chez les mammiferes | |
AU1287197A (en) | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines | |
Bach | Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases | |
CA2108886A1 (fr) | Molecules dirigees contre les recepteurs a interleukine pour le traitement de l'arthrite inflammatoire | |
Bach | Immunotherapy of insulin-dependent diabetes mellitus | |
DE69734392T2 (de) | Impfstoff gegen tumore der b-lymphozyten | |
EP0303687B1 (fr) | Compositions pour ameliorer les therapies adcc | |
JPH0641423B2 (ja) | 細胞毒性薬剤組成物及び細胞毒性薬剤キット | |
EP0883406A1 (fr) | Utilisation de l'il-7 dans le traitement des maladies auto-immunes, en particulier le diabete mellitus insulinodependant | |
MAUFF et al. | A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipients. | |
Galili et al. | Understanding the induced antibody response | |
De Jonge et al. | Bispecific antibody treatment of murine B cell lymphoma | |
Stępień et al. | Cytokine-targeted treatment in alopecia areata-new possibilities? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20161209 |